prednisone has been researched along with Carcinoma, Renal Cell in 31 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of everolimus and low-dose prednisone administered daily was hypothesized to prevent noninfectious pneumonitis (NIP) and mucositis, two common adverse events related to everolimus." | 5.24 | A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer. ( Amadori, D; Barone, D; Burgio, SL; De Giorgi, U; Gallà, V; Lolli, C; Maugeri, A; Schepisi, G; Vertogen, B, 2017) |
| " A diagnosis of hypophysitis was made, and he was immediately started on prednisone 1 mg/kg." | 3.91 | Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis. ( Gallagher, EJ; Galsky, M; Leiter, A; Thapi, S, 2019) |
| "Five responses (lung metastases, three; lymph node metastases, two) were observed in 23 patients with metastatic renal cell carcinoma who received recombinant interferon-alpha-2A (IFN) 18 X 10(6) U in three intramuscular doses each week combined with oral prednisone (10 to 20 mg daily)." | 3.68 | Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study. ( Fosså, SD; Gunderson, R; Moe, B, 1990) |
| "Prednisone has been shown to decrease IFN-alpha-related toxicity without reducing the response rate." | 2.67 | Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study. ( Fosså, SD; Haarstad, H; Jacobsen, AB; Risberg, T; Schjølseth, SA, 1994) |
| "To evaluate the incidence, diagnosis and treatment of immune-related adverse events (e-irAE) of checkpoint inhibition (ICI) in metastatic urothelial carcinoma (mUC) and metastatic renal cell carcinoma (mRCC)." | 1.91 | Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors. ( Burger, M; Büttner, R; Oppolzer, IA; Riester, J; Schnabel, MJ, 2023) |
| "We describe a patient with metastatic renal cell carcinoma and a history of Crohn's disease who was treated with sunitinib and developed a severe exacerbation of Crohn's disease." | 1.40 | Severe exacerbation of Crohn's disease during sunitinib treatment. ( Boers-Sonderen, MJ; Hoentjen, F; Jacobs, JF; Mulder, SF; Nagtegaal, ID; van Herpen, CM; Wanten, GJ, 2014) |
| "In patient B, progression of renal cell carcinoma was found more than a half year later." | 1.36 | [Sweet syndrome in underlying malignancy]. ( Dercksen, MW; Nijziel, MR; Prins, M; ten Oever, J; van Hirtum, PV; Vreugdenhil, G, 2010) |
| "The histopathological diagnosis was renal cell carcinoma." | 1.31 | [Renal cell carcinoma in a patient with malignant lymphoma: a case report]. ( Senda, M; Takagi, Y; Tanaka, J, 2000) |
| "Treatment with aspirin and prednisone in one patient." | 1.29 | Anterior ischemic optic neuropathy secondary to interferon alfa. ( Purvin, VA, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 9 (29.03) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 10 (32.26) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Huynh, LM | 1 |
| Bonebrake, BT | 1 |
| DiMaio, DJ | 1 |
| Baine, MJ | 1 |
| Teply, BA | 1 |
| Oppolzer, IA | 1 |
| Riester, J | 1 |
| Büttner, R | 1 |
| Burger, M | 1 |
| Schnabel, MJ | 1 |
| Thapi, S | 1 |
| Leiter, A | 1 |
| Galsky, M | 1 |
| Gallagher, EJ | 1 |
| Remolina-Bonilla, YA | 1 |
| Jimenez-Franco, B | 1 |
| Lam, ET | 1 |
| Bourlon, MT | 1 |
| Lolli, C | 1 |
| Gallà, V | 1 |
| Schepisi, G | 1 |
| Barone, D | 1 |
| Burgio, SL | 1 |
| Maugeri, A | 1 |
| Vertogen, B | 1 |
| Amadori, D | 1 |
| De Giorgi, U | 1 |
| Ueharaguchi, Y | 1 |
| Kabashima, K | 1 |
| Sasahashi, M | 1 |
| Matsuda, A | 1 |
| Matubara, K | 1 |
| Matsui, M | 1 |
| Abrich, V | 1 |
| Duvuru, S | 1 |
| Swanson, HJ | 1 |
| Izzedine, H | 1 |
| Escudier, B | 1 |
| Rouvier, P | 1 |
| Gueutin, V | 1 |
| Varga, A | 1 |
| Bahleda, R | 1 |
| Soria, JC | 1 |
| Boers-Sonderen, MJ | 1 |
| Mulder, SF | 1 |
| Nagtegaal, ID | 1 |
| Jacobs, JF | 1 |
| Wanten, GJ | 1 |
| Hoentjen, F | 1 |
| van Herpen, CM | 1 |
| Piñar, D | 1 |
| Boix, E | 1 |
| Meana, JA | 1 |
| Herrero, J | 1 |
| van Hirtum, PV | 1 |
| Prins, M | 1 |
| ten Oever, J | 1 |
| Nijziel, MR | 1 |
| Vreugdenhil, G | 1 |
| Dercksen, MW | 1 |
| Maynard, JW | 1 |
| Christopher-Stine, L | 1 |
| Gelber, AC | 1 |
| Nadauld, LD | 1 |
| Miller, MB | 1 |
| Srinivas, S | 1 |
| Guo, R | 1 |
| Chang, L | 1 |
| Liu, Z | 1 |
| Li, AX | 1 |
| Huang, Q | 1 |
| Ann, DK | 1 |
| Wang, HC | 1 |
| Lin, CW | 1 |
| Wu, X | 1 |
| Yuan, YC | 1 |
| Yen, Y | 1 |
| Márquez Moreno, AJ | 1 |
| Mañas Uxó, J | 1 |
| Amores Ramírez, F | 1 |
| Aguilar Cuevas, R | 1 |
| Ortega Jiménez, MV | 1 |
| Leiva Vera, C | 1 |
| Pérez Rodríguez, D | 1 |
| Fujisawa, T | 1 |
| Aoshima, M | 1 |
| Uchiyama, N | 1 |
| Satoh, T | 1 |
| Ohmagari, N | 1 |
| Chonabayashi, N | 1 |
| Saiki, S | 1 |
| Suzuki, K | 1 |
| LAMBERG, BA | 1 |
| PELKONEN, R | 1 |
| FRICK, MH | 1 |
| Mohren, M | 1 |
| Essbach, U | 1 |
| Franke, A | 1 |
| Klink, A | 1 |
| Maas, C | 1 |
| Markmann, I | 1 |
| Pelz, AF | 1 |
| Jentsch-Ullrich, K | 1 |
| Christophersen, AO | 1 |
| Lie, AK | 1 |
| Fosså, SD | 4 |
| Phillips, PM | 1 |
| Newman, SA | 1 |
| Purvin, VA | 1 |
| Chu, SI | 1 |
| Kim, HJ | 1 |
| Skubitz, KM | 1 |
| Wong, MK | 1 |
| Bjarnason, GA | 1 |
| Hrushesky, WJ | 1 |
| Webster, P | 1 |
| Morava-Protzner, I | 1 |
| Towers, M | 1 |
| Dubernard, JM | 1 |
| Cloix, P | 1 |
| Tajra, LC | 1 |
| Alduglihan, W | 1 |
| Borson, F | 1 |
| Lefrançois, N | 1 |
| Martin, X | 1 |
| Haarstad, H | 1 |
| Jacobsen, AB | 1 |
| Schjølseth, SA | 1 |
| Risberg, T | 1 |
| Abouchacra, S | 1 |
| Duguid, WP | 1 |
| Somerville, PJ | 1 |
| Takagi, Y | 1 |
| Senda, M | 1 |
| Tanaka, J | 1 |
| Lehne, G | 1 |
| Gunderson, R | 2 |
| Hjelmaas, U | 1 |
| Holdener, EE | 1 |
| Zorn, BH | 1 |
| Taylor, RJ | 1 |
| Wood, RP | 1 |
| Stratta, RJ | 1 |
| Shaw, BW | 1 |
| Moe, B | 1 |
| Chasan, SA | 1 |
| Pothel, LR | 1 |
| Huben, RP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Oral PRednisone 5 mg Bid Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of Vascular Endothelial Growth Factor Receptor-tyrosine Kinase Inhibitors[NCT02479490] | Phase 2 | 8 participants (Actual) | Interventional | 2015-09-22 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisone and Carcinoma, Renal Cell
| Article | Year |
|---|---|
[A case of mediastinal metastasis of renal small cell carcinoma, performing CHOP therapy for an acute respiratory failure by the air way obstruction under the mechanical ventilation].
Topics: Acute Disease; Airway Obstruction; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal | 2003 |
Renal cell carcinoma presenting as nephrotic syndrome complicated by acute renal failure.
Topics: Acute Kidney Injury; Aged; Carcinoma, Renal Cell; Cyclophosphamide; Humans; Kidney Neoplasms; Male; | 1993 |
3 trials available for prednisone and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Everolimus; Female; | 2017 |
Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug | 1994 |
Recombinant interferon alpha-2A combined with prednisone in metastatic renal-cell carcinoma: treatment results, serum interferon levels and the development of antibodies.
Topics: Antibody Formation; Carcinoma, Renal Cell; Female; Humans; Interferon alpha-2; Interferon-alpha; Int | 1992 |
26 other studies available for prednisone and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
Topics: Aged; Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Doxycycline; Drug-Related Side Ef | 2021 |
Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors.
Topics: Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Humans; H | 2023 |
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
Topics: Adrenal Insufficiency; Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protoco | 2019 |
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Hum | 2020 |
A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Eruptions; Humans; Indo | 2013 |
Limited scleroderma with pauci-immune glomerulonephritis in the presence of renal cell carcinoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2013 |
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineopla | 2013 |
Severe exacerbation of Crohn's disease during sunitinib treatment.
Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; Crohn Disease; Disease Progression; Fatal Outcome; G | 2014 |
Sunitinib-induced thyrotoxicosis.
Topics: Aged; Antineoplastic Agents; Carbimazole; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; | 2009 |
[Sweet syndrome in underlying malignancy].
Topics: Aged; Carcinoma, Renal Cell; Disease Progression; Follow-Up Studies; Humans; Kidney Neoplasms; Male; | 2010 |
Testicular pain followed by microscopic hematuria, a renal mass, palpable purpura, polyarthritis, and hematochezia.
Topics: Adrenal Cortex Hormones; Adult; Arthritis; Carcinoma, Renal Cell; Gastrointestinal Hemorrhage; Hemat | 2010 |
Pyoderma gangrenosum with the use of sunitinib.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Chemotherapy, Adjuva | 2011 |
Canonical nuclear factor κB pathway links tumorigenesis of synchronous mantle-cell lymphoma, clear-cell renal-cell carcinoma, and GI stromal tumor.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2011 |
[Synchronous chromophobe renal carcinoma and centrocytic lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Ther | 2003 |
HYPERCALCAEMIA IN RENAL CARCINOMA. REPORT OF A CASE.
Topics: Alkaline Phosphatase; Blood; Bone Neoplasms; Calcium; Carcinoma; Carcinoma, Renal Cell; Electrocardi | 1964 |
Acute myelofibrosis in a patient with diffuse large cell non Hodgkin's lymphoma and renal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Renal Cell; Chromosome Aberr | 2003 |
Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Middle Aged; Neoplasm Regression, Spontaneo | 2006 |
Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Dipho | 2008 |
Anterior ischemic optic neuropathy secondary to interferon alfa.
Topics: Acute Disease; Adult; Aspirin; Carcinoma, Renal Cell; Fundus Oculi; Humans; Interferon-alpha; Ischem | 1995 |
Pulmonary toxicity of continuous infusion 5-fluoro-2'-deoxyuridine.
Topics: Aged; Carcinoma, Renal Cell; Floxuridine; Humans; Infusions, Intravenous; Kidney Neoplasms; Lung Dis | 1995 |
Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases.
Topics: Aged; Carcinoma, Renal Cell; Cough; Dyspnea; Female; Fever; Floxuridine; Forced Expiratory Volume; H | 1995 |
Simultaneous adrenal gland and kidney allotransplantation after synchronous bilateral renal cell carcinoma: a case report.
Topics: Adrenal Cortex; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Antilymphocyte Serum; Auto | 1995 |
[Renal cell carcinoma in a patient with malignant lymphoma: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cyclophosphamide; Doxor | 2000 |
Renal cell carcinoma in a liver transplant recipient.
Topics: Carcinoma, Renal Cell; Cholangitis, Sclerosing; Cyclosporins; Humans; Immunosuppression Therapy; Kid | 1991 |
Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Evaluation; | 1990 |
Management and prognostic significance of hypercalcemia in renal cell carcinoma.
Topics: Calcitonin; Calcium; Carcinoma, Renal Cell; Furosemide; Humans; Hypercalcemia; Indomethacin; Kidney | 1989 |